Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.

about

Intraspinal Transplantation of the Adipose Tissue-Derived Regenerative Cells in Amyotrophic Lateral Sclerosis in Accordance with the Current Experts' Recommendations: Choosing Optimal Monitoring Tools

P2860

Q58787909-4964B4BF-EBA3-4286-AC05-FB19716D2607

P2860

Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.

Item

http://www.wikidata.org/entity/Q47815494

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Exploring the diagnosis delay ...... for clinical trial enrolment.

@en

Exploring the diagnosis delay ...... for clinical trial enrolment.

@nl

type

Item

label

Exploring the diagnosis delay ...... for clinical trial enrolment.

@en

Exploring the diagnosis delay ...... for clinical trial enrolment.

@nl

prefLabel

Exploring the diagnosis delay ...... for clinical trial enrolment.

@en

Exploring the diagnosis delay ...... for clinical trial enrolment.

@nl

P1476

Exploring the diagnosis delay ...... for clinical trial enrolment.

@en

P2093

Bello Hamidou

http://www.w3.org/2001/XMLSchema#string

Christine Tranchant

http://www.w3.org/2001/XMLSchema#string

Fausto Viader

http://www.w3.org/2001/XMLSchema#string

Geraldine Lautrette

http://www.w3.org/2001/XMLSchema#string

Giroud Maurice

http://www.w3.org/2001/XMLSchema#string

Jean-Christophe Antoine

http://www.w3.org/2001/XMLSchema#string

Katell Beauvais

http://www.w3.org/2001/XMLSchema#string

Marie Nicol

http://www.w3.org/2001/XMLSchema#string

Marie-Christine Arnes-Bes

http://www.w3.org/2001/XMLSchema#string

Philippe Couratier

http://www.w3.org/2001/XMLSchema#string

P2860

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Natural history and clinical features of the flail arm and flail leg ALS variants

Phase II/III randomized trial of TCH346 in patients with ALS

The relationship between tirasemtiv serum concentration and functional outcomes in patients with ALS

Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research.

Incidence of amyotrophic lateral sclerosis in Europe.

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

P304

519-527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21678421.2017.1353098

http://www.w3.org/2001/XMLSchema#string

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28762856

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.

about

P2860

P2860

Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921